Advisors Preferred’s AMN Healthcare AMN Stock Holding History

Advisors Preferred’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,668	Closed	-$601K	–	200
2022 Q4	$601K	Buy	+5,668	New	+$653K	0.26%	45
2021 Q3	–	Sell	-20,222	Closed	-$1.98M	–	181
2021 Q2	$1.98M	Buy	+20,222	New	+$1.75M	0.2%	50

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Advisors Preferred's AMN Position: Q1 2023 in Review

Advisors Preferred sold out of AMN Healthcare (AMN) in Q1 2023, closing a stake of 5,668 shares — an estimated $601K sold.

Advisors Preferred first reported a position in AMN in Q2 2021 and held it in 2 quarters. The position peaked at $1.98M in Q2 2021. 453 funds tracked by Wall St. Rank hold AMN as of Q1 2023.

Advisors Preferred reported no remaining AMN Healthcare position as of Q1 2023 after selling out during the quarter.
Advisors Preferred sold 5,668 AMN Healthcare shares in Q1 2023, an estimated $601K.
Advisors Preferred first reported a position in AMN Healthcare in Q2 2021 and held it in 2 quarters.
Advisors Preferred's AMN Healthcare position peaked at $1.98M in Q2 2021.
453 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2023.

Based on Advisors Preferred's 13F filing for Q1 2023, filed 3 May 2023.